Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening


Ontology type: sgo:Patent     


Patent Info

DATE

2007-10-09T00:00

AUTHORS

CAPON DANIEL J , PETROPOULOS CHRISTOS J

ABSTRACT

This invention provides a method for determining susceptibility for an anti-viral drug comprising: (a) introducing a resistance test vector Comprising a patient-derived segment and an indicator gene into a host cell; (b) culturing the host cell from (a); (c) measuring expression of the indicator gene in a target host cell; and (d) comparing the expression of the indicator gene from (c) with the expression of the indicator gene measured when steps (a)-(c) are carried out in the absence of the anti-viral drug, wherein a test concentration of the anti-viral drug is present at steps (a)-(c); at steps (b)-(c); or at step (c). This invention also provides a method for determining anti-viral drug resistance in a patient comprising: (a) determining anti-viral drug susceptibility in the patient at a first time using the susceptibility test described above, wherein the patient-derived segment is obtained from the patient at about said time; (b) determining anti-viral drug susceptibility of the same patient at a later time; and (c) comparing the anti-viral drug susceptibilities determined in step (a) and (b), wherein a decrease in anti-viral drug susceptibility at the later time compared to the first time indicates development or progression of anti-viral drug resistance in the patient. More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "CAPON DANIEL J", 
        "type": "Person"
      }, 
      {
        "name": "PETROPOULOS CHRISTOS J", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/373117a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025418642", 
          "https://doi.org/10.1038/373117a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/373123a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014949926", 
          "https://doi.org/10.1038/373123a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/365451a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016663177", 
          "https://doi.org/10.1038/365451a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/348091a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037197500", 
          "https://doi.org/10.1038/348091a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/334320a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014592155", 
          "https://doi.org/10.1038/334320a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/374569a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012077404", 
          "https://doi.org/10.1038/374569a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-10-09T00:00", 
    "description": "

This invention provides a method for determining susceptibility for an anti-viral drug comprising: (a) introducing a resistance test vector Comprising a patient-derived segment and an indicator gene into a host cell; (b) culturing the host cell from (a); (c) measuring expression of the indicator gene in a target host cell; and (d) comparing the expression of the indicator gene from (c) with the expression of the indicator gene measured when steps (a)-(c) are carried out in the absence of the anti-viral drug, wherein a test concentration of the anti-viral drug is present at steps (a)-(c); at steps (b)-(c); or at step (c). This invention also provides a method for determining anti-viral drug resistance in a patient comprising: (a) determining anti-viral drug susceptibility in the patient at a first time using the susceptibility test described above, wherein the patient-derived segment is obtained from the patient at about said time; (b) determining anti-viral drug susceptibility of the same patient at a later time; and (c) comparing the anti-viral drug susceptibilities determined in step (a) and (b), wherein a decrease in anti-viral drug susceptibility at the later time compared to the first time indicates development or progression of anti-viral drug resistance in the patient.

", "endDate": "2017-05-23", "id": "sg:patent.US-7279279-B2", "name": "Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.419316.8", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-7279279-B2" ], "sdDataset": "patents", "sdDatePublished": "2022-10-01T07:03", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/patent/patent_42.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-7279279-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-7279279-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-7279279-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-7279279-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

54 TRIPLES      15 PREDICATES      22 URIs      9 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-7279279-B2 schema:about anzsrc-for:11
2 anzsrc-for:1108
3 schema:author Ncd9333380fbe466c8ed3edfe967cc937
4 schema:citation sg:pub.10.1038/334320a0
5 sg:pub.10.1038/348091a0
6 sg:pub.10.1038/365451a0
7 sg:pub.10.1038/373117a0
8 sg:pub.10.1038/373123a0
9 sg:pub.10.1038/374569a0
10 schema:datePublished 2007-10-09T00:00
11 schema:description <p num="p-0001">This invention provides a method for determining susceptibility for an anti-viral drug comprising: (a) introducing a resistance test vector Comprising a patient-derived segment and an indicator gene into a host cell; (b) culturing the host cell from (a); (c) measuring expression of the indicator gene in a target host cell; and (d) comparing the expression of the indicator gene from (c) with the expression of the indicator gene measured when steps (a)-(c) are carried out in the absence of the anti-viral drug, wherein a test concentration of the anti-viral drug is present at steps (a)-(c); at steps (b)-(c); or at step (c). This invention also provides a method for determining anti-viral drug resistance in a patient comprising: (a) determining anti-viral drug susceptibility in the patient at a first time using the susceptibility test described above, wherein the patient-derived segment is obtained from the patient at about said time; (b) determining anti-viral drug susceptibility of the same patient at a later time; and (c) comparing the anti-viral drug susceptibilities determined in step (a) and (b), wherein a decrease in anti-viral drug susceptibility at the later time compared to the first time indicates development or progression of anti-viral drug resistance in the patient.</p>
12 schema:endDate 2017-05-23
13 schema:name Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
14 schema:recipient grid-institutes:grid.419316.8
15 schema:sameAs https://app.dimensions.ai/details/patent/US-7279279-B2
16 schema:sdDatePublished 2022-10-01T07:03
17 schema:sdLicense https://scigraph.springernature.com/explorer/license/
18 schema:sdPublisher N88d72930695640ae9de0719e8ec0515a
19 sgo:license sg:explorer/license/
20 sgo:sdDataset patents
21 rdf:type sgo:Patent
22 N88d72930695640ae9de0719e8ec0515a schema:name Springer Nature - SN SciGraph project
23 rdf:type schema:Organization
24 Na9f6f3b869944b2bb759d848e4c07003 schema:name CAPON DANIEL J
25 rdf:type schema:Person
26 Ncd9333380fbe466c8ed3edfe967cc937 rdf:first Na9f6f3b869944b2bb759d848e4c07003
27 rdf:rest Nf4c20cf9227e432d80f43b573dcca212
28 Ne176721f6b5b40b3b4ab9397de59aac8 schema:name PETROPOULOS CHRISTOS J
29 rdf:type schema:Person
30 Nf4c20cf9227e432d80f43b573dcca212 rdf:first Ne176721f6b5b40b3b4ab9397de59aac8
31 rdf:rest rdf:nil
32 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
33 rdf:type schema:DefinedTerm
34 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
35 rdf:type schema:DefinedTerm
36 sg:pub.10.1038/334320a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014592155
37 https://doi.org/10.1038/334320a0
38 rdf:type schema:CreativeWork
39 sg:pub.10.1038/348091a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037197500
40 https://doi.org/10.1038/348091a0
41 rdf:type schema:CreativeWork
42 sg:pub.10.1038/365451a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016663177
43 https://doi.org/10.1038/365451a0
44 rdf:type schema:CreativeWork
45 sg:pub.10.1038/373117a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025418642
46 https://doi.org/10.1038/373117a0
47 rdf:type schema:CreativeWork
48 sg:pub.10.1038/373123a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014949926
49 https://doi.org/10.1038/373123a0
50 rdf:type schema:CreativeWork
51 sg:pub.10.1038/374569a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012077404
52 https://doi.org/10.1038/374569a0
53 rdf:type schema:CreativeWork
54 grid-institutes:grid.419316.8 schema:Organization
 




Preview window. Press ESC to close (or click here)


...